DOCSLIB.ORG

Normal Anatomy and Histology of Bone Marrow

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Normal Anatomy and Histology of Bone Marrow NORMAL ANATOMY AND 1 HISTOLOGY OF BONE MARROW FETAL HEMATOPOIESIS regulatory factors. This tightly regulated process In the developing embryo and fetus, hema- involves self-renewal of hematopoietic stem topoiesis is first detected in the yolk sac and cells and the production of lineage-committed sequentially in the dorsal aorta (aorta-gonad- progenitor cells; the latter undergo a cascade of mesonephros), liver, spleen, and finally the differentiation resulting in the diverse mature bone marrow. In the yolk sac, hematopoiesis hematolymphoid elements that are released occurs in the 2nd and 3rd embryonic weeks into the blood (15,28). and is characterized by the sequential forma- The hematopoietic specificity of bone mar- tion of waves of hematopoietic progenitor cells row–derived stem cells has been challenged, with limited reconstitution capacity (2,8). This and a “plasticity” of these stem cells has been site is restricted to the exclusive production of postulated (18). Although controversial, some nucleated erythroid cells within blood islands; evidence suggests that bone marrow–derived these primitive nucleated erythrocytes are the stem cells may be induced to give rise to various first circulating cells of the developing embryo nonhematolymphoid lineages such as muscle, (2,4,6,8). The earliest multilineage hematopoi- cartilage, and nerve (18). The recent detection of etic precursor cells are found in the embryonic a second category of stem cell, the mesenchymal dorsal aorta (aorta-gonad-mesonephros/para- stem cell, has prompted reconsideration of this aortic splanchnopleura) (1,2,4,8). Specialized hypothesis. Consequently, current investigators adhesion molecules produced by stromal cells propose that mesenchymal stem cells are the within both the yolk sac and dorsal aorta progenitors of nonhematopoietic lineages, not promote hematopoiesis and angiogenesis (5). the hematopoietic stem cells (13,21,22). These Indeed, a common in utero precursor cell for mesenchymal stem cells are a normal constitu- hematopoietic and endothelial cells has been ent of the bone marrow microenvironment and proposed and termed the hemangioblast (3,8). give rise to mesenchymal bone marrow stromal Stem cell migration to the fetal liver results constituents including fibroblasts, adipose cells, in hepatic hematopoiesis by about 6 weeks of endothelial cells, osteoblasts/osteocytes, and gestation, followed shortly thereafter (at about chondroblasts/chondrocytes (33). 7 weeks of gestation) by seeding of the fetal Hematopoietic stem cells are not specifi- spleen (1,6,7). Hematopoiesis is detected in cally identifiable by the traditional morpho- fetal bone marrow by 14 weeks of gestation, logic review of bone marrow aspirate smears, and bone marrow is the primary site of hema- although a resemblance to small lymphoid cells topoiesis throughout the rest of gestation. The is suggested. Instead, stem cells are defined by vertebral column is the most active site of fetal functional properties or immunophenotypic bone marrow hematopoiesis followed by femur, profile. Hematopoietic stem cells are capable of pelvis, fibula/tibia, and humerus (7). both self-renewal and multilineage differentia- tion, a proposed unique property of asymetric HEMATOPOIESIS cell division which results in one new stem cell and one daughter cell capable of differentiation Stem Cells (12,16). Immunophenotypic features of hema- The production of all hematolymphoid lin- topoietic stem cells include expression of CD34, eages within the bone marrow is achieved by c-kit, and Thy1, while both CD38 and specific lin- the coordinated interaction of hematopoietic eage markers are typically absent (18,20,27,28,35). stem cells, the bone marrow microenviron- Expression of CD34, other adhesion molecules, ment, and various stimulatory and inhibitory and chemokine and cytokine receptors is linked 1 Non-Neoplastic Disorders of Bone Marrow to the localization (homing) of hematopoietic matopoietic stem cell activity are influenced by stem cells in highly specific bone marrow mi- these bone marrow microenvironment niches croenvironment niches (33). (16,19,24,30,33,36). T cells within the bone The homing of hematopoietic stem cells and marrow microenvironment play a key role in progenitor cells is regulated by cytokines, che- hematopoietic regulation by stimulating vari- mokines, and adhesion molecules (14,24,30). ous target cells to produce either stimulatory or Stromal cells provide survival and regulatory inhibitory regulatory factors. Similarly, mono- signals by direct contact with stem/progenitor cytes/macrophages within the microenviron- cells within a microenvironmental niche (24). ment produce many cytokines such as interleu- Hematopoietic stem cells localize to the endos- kin (IL)1, IL6, granulocyte colony-stimulating teal region of bone marrow; key signaling inter- factor (G-CSF), and monocyte–colony-stimulat- actions between hematopoietic stem cells and ing factor (M-CSF), all of which interact directly subendosteal osteoblasts account for this unique with hematopoietic stem cells and progenitor localization (12a,16,23,26,30,33). Recent studies cells (19). These regulatory factors may be se- suggest a major role for osteoblasts in support- creted into the extracellular matrix or remain ing hematopoiesis and regulating the size of the cell surface associated (11,33). hematopoietic stem cell pool (12a,16,30,33). Regulatory Factors The selective paratrabecular localization of im- mature granulocytic cells can be appreciated Numerous cytokines play a critical role in by morphologic and immunohistochemical as- hematopoiesis (Table 1-1). The majority of these sessment. In contrast, both lineage-committed cytokines are produced within the bone marrow progenitor cells and terminally-differentiated microenvironment by T cells, macrophages, cells tend to localize to central regions of the osteoblasts, and various other mesenchymal medullary cavity (29). stromal cells (33,34). By binding to specific mem- The transition from the undifferentiated sta- brane receptors on target cells, these cytokines tus of hematopoietic stem cells to committed initiate a cascade of intracellular genetic events lineage-specific differentiation is characterized that promote proliferation and maturation (9). by the regulation of expression of lineage-spe- Steady state hematopoiesis is maintained by both cific genes (27). The expression of these lineage- stimulatory and inhibitory regulatory factor pro- specific genes allows the committed progenitor duction as listed in Table 1-1. Some cytokines act cells to respond to stimuli generated from bone on the earliest hematopoietic stem cells, while marrow microenvironment elements, ultimate- others control the proliferation and maturation ly resulting in the production of various mature of lineage-committed progenitor cells. progeny (27). Lineage commitment is associated Stem cell factor (SCF) is a prototypic early with the loss of the self-renewal capability. acting cytokine that is critical not only for sustaining hematopoiesis but also for stem cell Bone Marrow Microenvironment migration and adhesiveness (10). In addition to The functional unit of hematopoiesis, the its action on hematopoietic stem cells through bone marrow microenvironment, includes the interaction with its cognate receptor c-kit, SCF capillary-venous sinus, the surrounding extra- is also critical for mast cell proliferation, matura- cellular matrix, and stromal elements. This is tion, and survival, accounting for its alternate a highly organized, three-dimensional matrix name of mast cell growth factor. Other early composed of structural scaffolding produced acting cytokines include FLT3 (FMS-like tyrosine by bone marrow stromal cells (fibroblasts, kinase 3) ligand and IL1, IL3, IL6, and IL11. macrophages, endothelial cells, adipocytes, Granulocyte-monocyte–colony-stimulating and reticular cells). The extracellular matrix factor (GM-CSF) is also a multilineage cytokine includes regulatory factors as well as fibronectin, whose major action is on granulocytic and collagen, laminin, and various proteoglycans erythroid colony forming units in cell culture (25,29,33). Interactions with the bone marrow assays. Prototypic late-acting cytokines include microenvironment determine the fate of he- G-CSF, erythropoietin, and thrombopoietin, matopoietic stem cells, since all aspects of he- which stimulate lineage-committed progenitor 2 Normal Anatomy and Histology of Bone Marrow Table 1-1 HEMATOPOIETIC REGULATORY GROWTH FACTORSa Regulatory Factor Comments Early Acting Cytokines; Multilineage, Pleiotropic or Synergistic Growth Factors Stem cell factor Ligand for c-kit receptor In receptor tyrosine kinase superfamily Many other names: kit ligand, steel factor, mast cell growth factor Influences stem cell migration, adhesiveness, proliferation Required to support hematopoiesis Synergistic with other regulatory factors Granulocyte/monocyte colony-stimulating factor Multilineage cytokine (GM-CSF) Promotes cell survival by suppressing apoptosis Interleukins (IL) 1, 3, 4, 6, 7, 11, 12 Multilineage (including B and T cells) cytokines Synergistic with other interleukins; IL-6 critical for plasma cell production IL3 Multi-CSF, multilineage cytokine Promotes cell survival by suppressing apoptosis FLK2/FLT3 (FMS-like tyrosine kinase 3) ligand Multilineage growth factor in receptor tyrosine kinase superfamily Lineage-Specific Cytokines Granulocyte colony-stimulating factor (G-CSF) Proliferation, maturation of neutrophilic lineage Monocyte colony-stimulating
Load more

Recommended publications
  • Mass Cytometric Functional Profiling of Acute Myeloid Leukemia Defines Cell-Cycle and Immunophenotypic Properties That Correlate with Known Responses to Therapy
    Published OnlineFirst June 19, 2015; DOI: 10.1158/2159-8290.CD-15-0298 ReseaRch aRticle Mass Cytometric Functional Profiling of Acute Myeloid Leukemia Defines Cell-Cycle and Immunophenotypic Properties That Correlate with Known Responses to Therapy Gregory K. Behbehani1,2,3, Nikolay Samusik1, Zach B. Bjornson1, Wendy J. Fantl1,4, Bruno C. Medeiros2,3, and Garry P. Nolan1 Downloaded from cancerdiscovery.aacrjournals.org on September 25, 2021. © 2015 American Association for Cancer Research. Published OnlineFirst June 19, 2015; DOI: 10.1158/2159-8290.CD-15-0298 abstRact Acute myeloid leukemia (AML) is characterized by a high relapse rate that has been attributed to the quiescence of leukemia stem cells (LSC), which renders them resistant to chemotherapy. However, this hypothesis is largely supported by indirect evidence and fails to explain the large differences in relapse rates across AML subtypes. To address this, bone mar- row aspirates from 41 AML patients and five healthy donors were analyzed by high-dimensional mass cytometry. All patients displayed immunophenotypic and intracellular signaling abnormalities within CD34+CD38lo populations, and several karyotype- and genotype-specific surface marker patterns were identified. The immunophenotypic stem and early progenitor cell populations from patients with clinically favorable core-binding factor AML demonstrated a 5-fold higher fraction of cells in S-phase compared with other AML samples. Conversely, LSCs in less clinically favorable FLT3-ITD AML exhib- ited dramatic reductions in S-phase fraction. Mass cytometry also allowed direct observation of the in vivo effects of cytotoxic chemotherapy. SIGNIFICANCE: The mechanisms underlying differences in relapse rates across AML subtypes are poorly understood.
    [Show full text]
  • 1. Introduction and Literature Review
    1. Introduction and literature review 1.1 Introduction 1.1.1 Defintion of blood Blood is described as a specialized connective tissue,which circulates in a closed system of blood vessels. (Monica.C, 2009) 1.1.2 Blood components Plasma is 55% of the total blood ,plasma cosist of albumin,globulin,water,electrolyte and many other organic and inorganic substances. (Monica.C, 2009) Blood cells is 45% of total blood and encompass;White blood cells(WBCs),Red blood cells(RBCs),and Platelets(Plts). (Monica.C, 2009) 1.1.3 Function of blood -Respiration: transport of oxygen from the lung to tissues and carbon dioxide from tissues to the lungs. -Excreation:transport of metabolic waste to the lungs,kidneys,skin and intestine for removal. - Maintain of normal acid –base balance. -Nutrition of body . -Part of immune system. (Monica.C, 2009) 1 1.1.4 Haemopoiesis Is the general aspect of blood cells formation. (Monica.C, 2009) Haemopoiesis occurs at different anatomical sites the course of development from embryonic life to adult life this site is, up to 2 month of gestation.The haemopoiesis occurs in yolk sac of the embryo.This period called (Myeloblastic period). (Monica.C, 2009) 2-7 month of gestation, this period called (Haepatic period). (Monica.C, 2009) Only important site of all hemopoiesis site after birth,an exception is lymphocyte production which occur in other organ in addition to the bone marrow.This period called(Myeloid period). (Monica.C, 2009) 1.1.5 Development of haemopoiesis The general most commonly accepted view is that blood cells development from small population of stem cells.
    [Show full text]
  • A Comparative Study of Murine Mast Cell Progenitors
    Virginia Commonwealth University VCU Scholars Compass Theses and Dissertations Graduate School 2001 A Comparative Study of Murine Mast Cell Progenitors Shirley K. DeSimone Follow this and additional works at: https://scholarscompass.vcu.edu/etd Part of the Other Medicine and Health Sciences Commons © The Author Downloaded from https://scholarscompass.vcu.edu/etd/4529 This Dissertation is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact [email protected]. Virginia Commonwealth University School of Medicine This is to certifythat the dissertation prepared by Shirley K. DeSimone entitled "A Comparative Study of Murine Mast Cell Progenitors" has been approved by her committee as satisfactory completion of the disse1tation requirement for the degree of Doctor of Philosophy. Francine M. Marciano-Cabral, Ph.D., School of Medicine Jack L. Haar, Ph.D., Dean, School of Graduate Studies A Comparative Study of Murine Mast Cell Progenitors A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy at Virginia Commonwealth University By Shirley K. DeSimone Director: Thomas F. Huff, Ph.D. Professor, Microbiology and Immunology Virginia Commonwealth University Richmond, Virginia May, 2001 11 Acknowledgments I wish to thank my advisor, Dr. Thomas F. Hufffor his insight, guidance, and patience. also which to acknowledge the invaluable, unwavering, and loving support of my husband, friend and companion, Dr. John A. DeSimone. Thanks are also due to the consistently helpful graduate students of Dr.
    [Show full text]
  • Development of Plasmacytoid and Conventional Dendritic Cell Subtypes from Single Precursor Cells Derived in Vitro and in Vivo
    ARTICLES Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo Shalin H Naik1,2, Priyanka Sathe1,3, Hae-Young Park1,4, Donald Metcalf1, Anna I Proietto1,3, Aleksander Dakic1, Sebastian Carotta1, Meredith O’Keeffe1,4, Melanie Bahlo1, Anthony Papenfuss1, Jong-Young Kwak1,4,LiWu1 & Ken Shortman1 The development of functionally specialized subtypes of dendritic cells (DCs) can be modeled through the culture of bone marrow with the ligand for the cytokine receptor Flt3. Such cultures produce DCs resembling spleen plasmacytoid DCs (pDCs), http://www.nature.com/natureimmunology CD8+ conventional DCs (cDCs) and CD8– cDCs. Here we isolated two sequential DC-committed precursor cells from such cultures: dividing ‘pro-DCs’, which gave rise to transitional ‘pre-DCs’ en route to differentiating into the three distinct DC subtypes (pDCs, CD8+ cDCs and CD8– cDCs). We also isolated an in vivo equivalent of the DC-committed pro-DC precursor cell, which also gave rise to the three DC subtypes. Clonal analysis of the progeny of individual pro-DC precursors demonstrated that some pro-DC precursors gave rise to all three DC subtypes, some produced cDCs but not pDCs, and some were fully committed to a single DC subtype. Thus, commitment to particular DC subtypes begins mainly at this pro-DC stage. Dendritic cells (DCs) are antigen-presenting cells crucial for the innate macrophages12. Further ‘downstream’, ‘immediate’ precursors have and adaptive response to infection as well as for maintaining immune been identified for several DC types, including Ly6Chi monocytes as 3,4,6 13 Nature Publishing Group Group Nature Publishing tolerance to self tissue.
    [Show full text]
  • Effects of Heterologous Antineutrophil Serum in Guinea Pigs Hematologic and Ultrastructural Observations
    Effects of Heterologous Antineutrophil Serum in Guinea Pigs Hematologic and Ultrastructural Observations David M. Simpson and Russell Ross Two pools of rabbit anti-guinea pig neutrophil serum (ANS) were prepared using an intravenous (ANS I) or subcutaneous (ANS II) route of immunization with proteose peptone-stimulated peritoneal exudate neutrophils (PMNs) from albino guinea pigs. In vitro, both pools of ANS contained high titers of agglutinating antibodies to neutrophils and lower titers against lymphocytes and red cells. Ag- glutinins against all three cell types could be selectively removed by absorption. The in vivo hematologic effects of both the absorbed and unabsorbed antisera were examined after intraperitoneal administration, and the effects of ANS on neu- trophils in blood, bone marrow, and peritoneal cavity were examined by light and electr microscopy of spleen, liver, lung, lymph node, buffy coat, bone mar- row and pellets of peritoneal cells removed at various time intervals within 24 hours. Injection of either antisera caused a rapid decrase in circulating neu- trophils and lymphocytes, whi reached thefr lowest levels within 12 hours. Neutrophils that disappeared from the circulation were sequestered primarily in liver and spleen where they were phagocytized, as morphologically intact cells, by macrophages and then rapidly digested. Immature bone marow neutrophils as young as early myelocytes were ingested by macrophages in the marrow at 6 hours or later after ANS. Neutrophils that were phagocytized were apparently opsonized by ANS since there was no ultrastructurl evidence of neutrophil lysis in blood or bone manrow after ANS treatment. However, both lysed and ingested neubrophils were observed in the peritoneal cavity.
    [Show full text]
  • The Biochemical and Biophysical Mechanisms of Macrophage Migration
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations 2015 The Biochemical and Biophysical Mechanisms of Macrophage Migration Laurel Erin Hind University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Allergy and Immunology Commons, Biomedical Commons, Immunology and Infectious Disease Commons, and the Medical Immunology Commons Recommended Citation Hind, Laurel Erin, "The Biochemical and Biophysical Mechanisms of Macrophage Migration" (2015). Publicly Accessible Penn Dissertations. 1062. https://repository.upenn.edu/edissertations/1062 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/1062 For more information, please contact [email protected]. The Biochemical and Biophysical Mechanisms of Macrophage Migration Abstract The ability of macrophages to migrate is critical for a proper immune response. During an innate immune response, macrophages migrate to sites of infection or inflammation where they clear pathogens through phagocytosis and activate an adaptive immune response by releasing cytokines and acting as antigen- presenting cells. Unfortunately, improper regulation of macrophage migration is associated with a variety of dieases including cancer, atherosclerosis, wound-healing, and rheumatoid arthritis. In this thesis, engineered substrates were used to study the chemical and physical mechanisms of macrophage migration. We first used microcontact printing to generate surfaces
    [Show full text]
  • Differentiation of Pluripotent Cells Differenzierung Pluripotenter Zellen Différenciation De Cellules Pluripotentes
    (19) TZZ Z_¥_T (11) EP 2 401 364 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: C12N 5/0781 (2010.01) C12N 5/071 (2010.01) 22.04.2015 Bulletin 2015/17 (86) International application number: (21) Application number: 10707179.7 PCT/US2010/025776 (22) Date of filing: 01.03.2010 (87) International publication number: WO 2010/099539 (02.09.2010 Gazette 2010/35) (54) DIFFERENTIATION OF PLURIPOTENT CELLS DIFFERENZIERUNG PLURIPOTENTER ZELLEN DIFFÉRENCIATION DE CELLULES PLURIPOTENTES (84) Designated Contracting States: • WANG LISHENG ET AL: "Endothelial and AT BE BG CH CY CZ DE DK EE ES FI FR GB GR hematopoietic cell fate of human embryonic stem HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL cells originates from primitive endothelium with PT RO SE SI SK SM TR hemangioblastic properties" IMMUNITY, CELL PRESS, US LNKD- DOI:10.1016/J.IMMUNI. (30) Priority: 27.02.2009 US 156304 P 2004.06.006, vol. 21, no. 1, 1 July 2004 (2004-07-01), pages 31-41, XP002484358 ISSN: (43) Date of publication of application: 1074-7613 04.01.2012 Bulletin 2012/01 • BHATIA MICKIE: "Hematopoiesis from human embryonic stem cells." ANNALS OF THE NEW (73) Proprietor: Cellular Dynamics International, Inc. YORK ACADEMY OF SCIENCES JUN 2007 LNKD- Madison, WI 53711 (US) PUBMED:17332088, vol. 1106, June 2007 (2007-06), pages 219-222, XP007912752 ISSN: (72) Inventors: 0077-8923 • RAJESH, Deepika • KENNEDY MARION ET AL: "Development of the Madison, WI 53711 (US) hemangioblast defines the onset of • LEWIS, Rachel hematopoiesis in human ES cell differentiation Madison, WI 53711 (US) cultures" BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, vol.
    [Show full text]
  • The Term Meaning White Blood Cells Is
    The Term Meaning White Blood Cells Is Micro Angelico still desalinate: venatic and unclimbed Elliot originate quite significatively but globes her proximocracoviennes and admeasuring catechetically. politely. Welsh Hazardableis attritional orand pollened, endows Sherwood voicelessly never as statant comb-outs Ira interpenetrates any output! Trophoblast cells are destined to give rise to many of the extraembryonic tissues. Genetic disorders and blood the cells is a permanent hair shaft, great care provider first line reported by lab technician may be included in circulation, the superficial veins. The part of the brain that controls coordinated movement. What Is A Medical Technologist? Inflammation of the liver. MPV is used along with platelet count to diagnose some diseases. After circulating in the bloodstream for about a day, monocytes enter body tissues to become macrophages, which can destroy some germs by surrounding and digesting them. The legacy of this great resource continues as the Merck Veterinary Manual in the US and Canada and the MSD Manual outside of North America. An abnormal increase in the volume of circulating blood. These small cells seem to sound an alarm when infectious agents invade your blood. Comparisons may be useful for a differential diagnosis. Finally, emotional or physical stress can also cause elevated white blood cell counts. The ability of the body to learn to fight specific infections after being exposed to the germs that cause them. However, you may also visit the Cookie Settings at any time to provide controlled consent, and you can withdraw your consent there. Severe pain that occurs suddenly and usually lasts a short while.
    [Show full text]
  • CDG and Immune Response: from Bedside to Bench and Back Authors
    CDG and immune response: From bedside to bench and back 1,2,3 1,2,3,* 2,3 1,2 Authors: Carlota Pascoal , Rita Francisco , Tiago Ferro , Vanessa dos Reis Ferreira , Jaak Jaeken2,4, Paula A. Videira1,2,3 *The authors equally contributed to this work. 1 Portuguese Association for CDG, Lisboa, Portugal 2 CDG & Allies – Professionals and Patient Associations International Network (CDG & Allies – PPAIN), Caparica, Portugal 3 UCIBIO, Departamento Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, 2829-516 Caparica, Portugal 4 Center for Metabolic Diseases, UZ and KU Leuven, Leuven, Belgium Word count: 7478 Number of figures: 2 Number of tables: 3 This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1002/jimd.12126 This article is protected by copyright. All rights reserved. Abstract Glycosylation is an essential biological process that adds structural and functional diversity to cells and molecules, participating in physiological processes such as immunity. The immune response is driven and modulated by protein-attached glycans that mediate cell-cell interactions, pathogen recognition and cell activation. Therefore, abnormal glycosylation can be associated with deranged immune responses. Within human diseases presenting immunological defects are Congenital Disorders of Glycosylation (CDG), a family of around 130 rare and complex genetic diseases. In this review, we have identified 23 CDG with immunological involvement, characterised by an increased propensity to – often life-threatening – infection.
    [Show full text]
  • Single-Cell Mass Cytometry of Differential Immune and Drug
    RESEARCH ARTICLE Performance assessmentofmasscytometry. The workflow for mass cytometry is comparable with that of fluorescence flow cytometry (Fig. 1A). Single-Cell Mass Cytometry of Differential Antibodies coupled to distinct, stable, transition element isotopes were used to bind target epitopes on and within cells. Cells, with bound antibody- Immune and Drug Responses Across isotope conjugates, were sprayed as single-cell droplets into an inductively coupled argon plasma a Human Hematopoietic Continuum (created by passing argon gas through an induc- tion coil with a high radio-frequency electric cur- 1 1 2 3 1 1 Sean C. Bendall, * Erin F. Simonds, * Peng Qiu, El-ad D. Amir, Peter O. Krutzik, Rachel Finck, rent) at approximately 5500 K. This vaporizes 1,7 3 1 4,5 6 Robert V. Bruggner, Rachel Melamed, Angelica Trejo, Olga I. Ornatsky, Robert S. Balderas, each cell and induces ionization of its atomic con- 2 1 3 4,5 1 Sylvia K. Plevritis, Karen Sachs, Dana Pe’er, Scott D. Tanner, Garry P. Nolan † stituents. The resulting elemental ions were then sampled by a time-of-flight (TOF) mass spectrom- Flow cytometry is an essential tool for dissecting the functional complexity of hematopoiesis. We used eter and quantified. The signal for each transi- single-cell “mass cytometry” to examine healthy human bone marrow, measuring 34 parameters tion element isotope reporter was integrated as simultaneously in single cells (binding of 31 antibodies, viability, DNA content, and relative cell size). The each cell’s constituent ions reached the detector. signaling behavior of cell subsets spanning a defined hematopoietic hierarchy was monitored with 18 Currently, TOF sampling resolution enables the simultaneous markers of functional signaling states perturbed by a set of ex vivo stimuli and inhibitors.
    [Show full text]
  • Haematopoiesis to Describe the Components of Normal Blood, Their Relative Proportions and Their Functions
    Haematopoiesis To describe the components of normal blood, their relative proportions and their functions Blood 8% of body weight Plasma (55%) clear, 90% water, contains salts, enzymes, proteins WBCs and platelet (1%) RBCs (45%) bioconcave– disc, no nucleus = anuclear- 120days lifespan Immature = blasts– Mature= cytes In white blood cells myeloblast goes to neutrophils, basophils, eosinophils Monoblast= monocyte can also become dendritic cells and macrophages – White blood cells (leukocytes)– Polymorphonuclear= neutrophils, eosinophil s, basophils Mononuclear= lymphocytes= T cells, B cells and’ monocytes Lymphoid= NK cells, T-Lymphocyte, B-lymphocyte Myeloid= Monocyte, erythrocyte, neutrophils, basophils, eosinophils, mast cells, megakaryocyte, mast cells BOTH Dendritic cells (from monocyte in myeloid) (lymphoid precursor) Neutrophil – protection from bacteria and fungi Eosinophil- protection against parasites Basophil – increase during allergic reactions Lymphocytes – T cells- protection against viruses, B cells immunoglobulin synthesis Monocyte- protection from back bacteria and fungi phagocytosis – How do blood go from bone to blood vessels? – The bones are perfused with blood vessels- How do we investigate blood? In venepuncture, the superficial veins of the upper limbs are selected and hollow needle is inserted through the skin into the veins. Blood is then collected into evacuated tubes. These veins are present in numbers and are easily accessible. Anticoagulant, EDTA is used to stop blood clotting 1.Using Automated the sample full collected…. blood count Whole blood for a FBC is usually taken into an EDTA tube to stop it from clotting. The blood is well mixed and put through a machine called an automated analyser, counts the numbers and size of RBC and platelets within the blood using sensors Reticulocyte Assessing the young RBCs numbers performed by automated cell counters give indication of output of young RBC by bone marrow – 2.
    [Show full text]
  • 1 the Potential Role of Cytokines and Growth Factors in the Pathogenesis
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 10 August 2021 doi:10.20944/preprints202108.0237.v1 The Potential Role of Cytokines and growth factors in the pathogenesis of Alzheimer's Disease Gilbert Ogunmokun1, Saikat Dewanjee2, Pratik Chakraborty2, Chandrasekhar Valupadas3,4 Anupama Chaudhary5, Viswakalyan Kolli6, Uttpal Anand7, Jayalakshmi Vallamkondu8, Parul Goel9, Hari Prasad Reddy Paluru10, Kiran Dip Gill11, P. Hemachandra Reddy12-16 , Vincenzo De Feo17*, ,Ramesh Kandimalla18,19*, 1The University of Texas Health Science Center at Houston (UTHealth) School of Public Health, Houston, Texas, USA 2Advanced Pharmacognosy Research Laboratory, Department of Pharmaceutical Technology, Jadavpur University, Kolkata 700032, India 3Professor, Internal Medicine & Medical Superintendent, MGM Hospital, Warangal, India 4In charge Medical Superintendent, KMC Superspeciality Hospital, Warangal, India 5Orinin-BioSystems, LE-52, Lotus Road 4, CHD City, Karnal, Karnal, Haryana -132001, India 6Professor, Department of Biochemistry, GITAM Institute of Medical Sciences and Research, Visakhapatnam, India 7Department of Life Sciences and the National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva, Israel 8National Institute of Technology, Warangal 506004, Telangana, India 9Department of Biochemistry, Maharishi Markandeshwar Institute of Medical Sciences & Research, Mullana, Ambala, India 10Sri Krsihnadevaraya University, Anantapur, Andhra Pradesh, India 11Department of Biochemistry, Posgraduate Institute
    [Show full text]